# Poland pharmaceutical regulation and cost reforms

> Live situation record from CLSTR: https://clstr.news/situations/poland-pharmaceutical-regulation-reforms
> Updated: 2026-09-09T11:48:44.000Z. Sources: 29. Developments: 8.

By late August 2026, the Ministry of Health introduced measures to manage the National Health Fund deficit and drug security. To address rising costs, the Ministry planned to reduce the list of free medications for seniors aged 65 and older, potentially removing up to 1,500 items if manufacturers do not lower prices. To combat pharmaceutical waste, new prescription regulations were proposed, including limits on treatment days per prescription and individual reimbursement accounts. Regarding advertising, the government continued drafting amendments to the Pharmaceutical Law to align with a CJEU ruling. These changes aim to replace a total ban with specific restrictions against misleading ads or targeting minors, though authorities warned of a regulatory gap during implementation. Additionally, following industry pushback regarding economic and constitutional concerns, the Ministry withdrew a proposal to drastically increase financial penalties for violations related to dietary supplements and fortified foods. In September 2026, new strategic directions were presented at the Karpacz Economic Forum under a new ‘Drug Policy’ framework. This framework aims to increase pharmaceutical security by creating regulations for drug supply during wartime and simplifying vaccinations through a ‘single window’ system. The Ministry also proposed replacing the current reimbursement budget with a multi-year financial plan for pharmacy drugs and chemotherapy programs. Regarding the senior medication list, the Ministry clarified that while approximately 1,500 commercial products may be removed by October 2026, seniors will not lose access to necessary active substances, as they will instead receive free generic equivalents. To qualify for free medication, patients must be at least 65, the drug must be on the official list, and the prescription must include the ‘S’ symbol, which can be issued by primary care physicians, specialists, or authorized nurses.

## Timeline

### 2026-09-09: Poland updates free medication rules for seniors in 2026

Poland is updating its free medication list for seniors in 2026. While some commercial brands may be removed, seniors will maintain access via free generic equivalents and expanded prescribing rights.

4 sources. https://clstr.news/cluster/poland-updates-free-medication-rules-for-seniors-in-2026

### 2026-09-09: Poland introduces new drug policy and healthcare management reforms

Polish health officials and academic leaders at the Karpacz Forum announced new drug policies to increase security and signed a declaration to reform healthcare facility management.

4 sources. https://clstr.news/cluster/poland-introduces-new-drug-policy-and-healthcare-management-reforms

### 2026-09-02: Poland updates regulations for pharmacy advertising and dietary supplements

Poland is amending laws to allow regulated pharmacy advertising following a CJEU ruling and has scaled back proposed massive fines for dietary supplement violations after industry protests.

8 sources. https://clstr.news/cluster/poland-updates-regulations-for-pharmacy-advertising-and-dietary-supplements

### 2026-08-31: Poland implements pharmaceutical reforms to manage costs and shortages

Poland's Ministry of Health is planning to cut free medications for seniors and introduce new prescription limits to manage rising costs, drug shortages, and significant pharmaceutical waste.

8 sources. https://clstr.news/cluster/poland-implements-new-measures-to-curb-drug-waste-and-pharmaceutical-costs

### 2026-08-22: Poland amends pharmaceutical laws following EU court ruling

Poland is amending its Pharmaceutical Law following a CJEU ruling against overly broad advertising bans, while pharmacists seek expanded professional services and improved prescription validation.

2 sources. https://clstr.news/cluster/poland-amends-pharmaceutical-laws-following-eu-court-ruling

### 2026-08-10: Poland moves to lift long-standing pharmacy advertising ban

Poland has submitted a bill to the Sejm to lift the 14-year ban on pharmacy advertising, aligning national law with EU rulings while implementing strict protections against misleading marketing.

2 sources. https://clstr.news/cluster/poland-moves-to-lift-long-standing-pharmacy-advertising-ban

### 2026-08-07: Poland expands partial e‑prescription fulfillment as drug‑refund law changes spark industry backlash

Poland's e‑prescription system now supports partial fulfillment across 580+ pharmacies, while new drug‑refund law amendments—added without consultation—have provoked strong opposition from the pharmaceutical行业.

2 sources. https://clstr.news/cluster/poland-expands-partial-eprescription-fulfillment-as-drugrefund-law-changes-spark-industry-backlash

### 2026-08-04: Poland lifts ban on pharmacy advertising, introduces stricter consumer safeguards

Poland’s cabinet approved a law ending the total ban on pharmacy ads, allowing limited advertising with new protections for children and higher fines, effective 14 days after publication.

6 sources. https://clstr.news/cluster/poland-lifts-ban-on-pharmacy-advertising-introduces-stricter-consumer-safeguards

---
Cite as: Poland pharmaceutical regulation and cost reforms. CLSTR, https://clstr.news/situations/poland-pharmaceutical-regulation-reforms
